53 results
8-K
EX-1.1
VERV
Verve Therapeutics Inc
29 Nov 23
Verve Therapeutics Announces Pricing of Public Offering of Common Stock and Concurrent Private Placement
4:54pm
, and neither the Representatives nor the other Underwriters shall have any responsibility or liability to the Company with respect thereto. Any
424B5
VERV
Verve Therapeutics Inc
29 Nov 23
Prospectus supplement for primary offering
4:47pm
no responsibility for, and can provide no assurance as to the reliability of, any other information that others may give you. This prospectus supplement … , warrant agent or unit agent will have any responsibility or liability for any aspect of the records relating to payments made on account
424B5
jvoa1uk3 5jvrnzp
28 Nov 23
Prospectus supplement for primary offering
4:25pm
S-3ASR
EX-4.4
tjr9s
23 Sep 22
Automatic shelf registration
4:08pm
S-3ASR
07pyt86sa9sqi2k0
23 Sep 22
Automatic shelf registration
4:08pm
S-3ASR
EX-4.5
m1ut0py
23 Sep 22
Automatic shelf registration
4:08pm
8-K
EX-1.1
5kbix 1yhzyj5ff
21 Jul 22
Verve Therapeutics Announces Pricing of Upsized Public Offering of Common Stock
4:46pm
424B5
xm7 4onb3
21 Jul 22
Prospectus supplement for primary offering
4:43pm